Table 2 Most frequently mentioned themes concerning the benefits, drawbacks, and obstacles to collaboration on product listing agreements
Number of policy makers that mentioned theme(n = 9) | |
|---|---|
Benefits | |
Increased bargaining power | 7 |
Provincial equity in price | 5 |
Provincial equity in access | 5 |
Administrative efficiency | 2 |
Increased access, can fund more drugs | 1 |
Drawbacks | |
Delay/length of process | 5 |
Reduction in provincial autonomy | 4 |
Savings may be lost for large provinces | 2 |
Resource-intensive | 2 |
Decreased access in some jurisdictions | 1 |
Barriers | |
Differences in policy institutions | 6 |
Provincial and/or federal will | 6 |
Differences structure of drug benefit programs | 5 |
Technical and administrative resources | 5 |
Political acceptability of the decision | 4 |